Hairloss progress photos: Dp you think this is a good position?
    Is this regrowth? 6/1/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Ketoconazole →

    antifungal with some anti-androgenic benefits, often used as a shampoo

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg
    💧 Minoxidil (topical) 5% 2 months
    💧 Ketoconazole (topical)
    the tone is 😀 positive with full hairline recovery results.

    Other terms

    A 33-year-old experienced hairline improvement using finasteride and minoxidil, later stopping minoxidil while continuing ketoconazole shampoo. Initial side effects included shedding, reduced libido, and anxiety, but these resolved, leading to a full hairline recovery.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community 1 year of min+fin+ketoconazole

       1054 upvotes 2 years ago
      The user has been using minoxidil daily, finasteride three times a week, and ketoconazole 1-3 times a week for a year to treat hair loss, resulting in noticeable hair regrowth at the hairline and temples, with minor side effects like itching and dandruff. They started with minoxidil a month before the other treatments and experienced an initial shedding phase for about six weeks.

      community Started finasteride in 09/2023. The top photo is from about a year before I started finasteride + minoxidil. The bottom photo is now at age 37.

       291 upvotes 4 months ago
      The user started finasteride and minoxidil in 2023 and added other treatments like ketoconazole shampoo and a Theradome helmet, noting some improvement but also experiencing fluctuations in hair density. They are considering adding low-dose dutasteride to their regimen and are seeking advice on distinguishing between normal hair changes and actual hair loss progression.

      community 2 years of me being on fin+min

      in Progress Pictures  1216 upvotes 1 year ago
      The conversation discusses hair loss treatments, specifically the use of oral finasteride and topical minoxidil, with the user sharing their two-year progress and routine. The user experienced initial shedding but saw improvements after six months, and they recently started taking dutasteride.

    Related Research

    6 / 6 results
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
      Hair Loss in Women: Comprehensive Overview and Treatment Options

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.
      Managing Patterned Hair Loss – A Hair Raising Task!

      research Managing patterned hair loss – a hair raising task!

      October 2021 in “Cosmoderma”
      This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
      Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review

      research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review

      66 citations , June 2018 in “International Journal of Women's Dermatology”
      This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.